意大利TK2缺陷的国家诊断差距:来自AIM多中心调查的见解
Michelangelo Mancuso1, Costanza Lamperti2, Olimpia Musumeci3
1Department of Clinical and Experimental Medicine, Neurological Institute, University of Pisa, Pisa, Italy.
概括
意大利的临床医生高度意识到胺基酶2 (TK2) 缺乏,但诊断方法不一致. 为及时诊断和未来的治疗提供标准化基因组包含和查协议至关重要.
科学领域:
- 遗传学 是一个遗传学.
- 神经学 神经学
- 线粒体疾病 线粒体疾病
背景情况:
- 乙胺基因酶2 (TK2) 缺乏症是一种罕见的线粒体疾病,具有不同的临床表现和正在开发的疗法.
- 早期诊断TK2缺乏症对于有效的患者管理和改善结果至关重要.
- 评估当前的临床实践对于提高诊断策略至关重要.
研究的目的:
- 评估意大利神经肌肉专家对提米丁激酶2 (TK2) 缺乏症的认识.
- 检查当前的诊断方法和将TK2查纳入遗传测试小组.
- 衡量意大利将TK2查纳入常规临床实践的准备程度.
主要方法:
- 在意大利肌肉学协会 (AIM) 的临床医生中进行了一项全国性调查.
- 调查问卷重点关注TK2缺陷意识,诊断途径,遗传小组组成和查态度.
- 在特定神经肌肉表型的遗传未解决病例中收集了TK2查的数据.
主要成果:
- 在被调查的临床医生中,对TK2缺乏的认识几乎是普遍的.
- 然而,将TK2纳入遗传面板显示出变异性:代谢肌病面板的85%,肢体带肌肉缩 (LGMD) 面板的56%.
- 在未解决脊髓肌肉缩 (SMA),FSHD和OPMD表型的患者中,对TK2的查不一致.
结论:
- 尽管有广泛的认识,但TK2缺乏症的诊断策略仍然不一致.
- 将TK2基因测试纳入下一代测序 (NGS) 面板中的标准化至关重要.
- 促进差异性查协议将促进早期诊断,特别是考虑到新出现的治疗选择.
更多相关视频
05:35Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
1.3K
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
3.0K
相关概念视频
01:26Pulmonary Tuberculosis IV
469
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
469
01:29Therapeutic Drug Monitoring: Affecting Factors
189
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
189
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
168
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
168